Quinn, D. I., Tangen, C. M., Hussain, M., Lara, P. N., Goldkorn, A., Moinpour, C. M., . . . Thompson, I. M. (2013). Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): A randomised phase 3 trial. Lancet Oncol.
Styl ChicagoQuinn, David I., et al. "Docetaxel and Atrasentan Versus Docetaxel and Placebo for Men With Advanced Castration-resistant Prostate Cancer (SWOG S0421): A Randomised Phase 3 Trial." Lancet Oncol 2013.
Citace podle MLAQuinn, David I., et al. "Docetaxel and Atrasentan Versus Docetaxel and Placebo for Men With Advanced Castration-resistant Prostate Cancer (SWOG S0421): A Randomised Phase 3 Trial." Lancet Oncol 2013.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..